MS

EU Panel Recommends That Elan Update Tysabri MS Drug Label
Bloomberg
Mon, 04/18/11 - 10:59 am
Europe
Elan
MS
multiple sclerosis
Tysabri
Genzyme advances key drug in Sanofi deal
Bizjournals.com
Thu, 04/14/11 - 06:23 pm
Genzyme
Sanofi
MS
multiple sclerosis
alemtuzumab
Teva’s MS Pill Reduces Relapses Less Than Most Injected Drugs, Study Finds
Bloomberg
Tue, 04/12/11 - 09:24 am
Teva Pharmaceuticals
MS
multiple sclerosis
Copaxone
Biogen Idec MS drug meets goal in late-stage study
Yahoo/AP
Mon, 04/11/11 - 11:43 am
Biogen Idec
MS
BG-12
multiple sclerosis
Avanir Pharmaceuticals Announces Filing of IND for AVP-923 for the Treatment of Central Neuropathic Pain in Patients with Multiple Sclerosis
Yahoo
Mon, 04/4/11 - 11:37 am
neuropathic pain
MS
multiple sclerosis
AVP-923
Avanir
Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs
Bloomberg
Tue, 03/22/11 - 11:07 am
Novartis
Gilenya
MS
multiple sclerosis
Teva Pharmaceuticals
Biogen Idec
Roche
Novartis gets EU approval for oral MS drug
Yahoo/AP
Mon, 03/21/11 - 11:19 am
Europe
MS
Novartis
multiple sclerosis
Teva Says Doctors Contacted on Trial of Generic Copaxone Drug
Bloomberg
Tue, 03/8/11 - 09:37 am
Teva Pharmaceuticals
generics
Copaxone
MS
multiple sclerosis
Merck KGaA Drug Fails to Convince FDA
WSJ Online
Wed, 03/2/11 - 11:56 am
Merck KGaA
FDA
cladribine
MS
multiple sclerosis
Teva Risks Disappointments as Top Drug Faces Threats
Bloomberg
Wed, 02/9/11 - 11:50 am
Teva Pharmaceuticals
Copaxone
generics
MS
multiple sclerosis
Acorda, Biogen fall on EU drug rejection
Marketwatch
Fri, 01/21/11 - 10:13 am
Acorda Therapeutics
Europe
Biogen Idec
Fampyra
MS
multiple sclerosis
Novartis MS Pill Wins European Backing as Rival Acorda Rejected
Bloomberg
Fri, 01/21/11 - 10:11 am
Novartis
MS
multiple sclerosis
Europe
Acorda Therapeutics
Gilenya
Merck KGaA
Biotech Firms Fight Generics
WSJ Online
Thu, 01/13/11 - 01:14 pm
generics
biotech
Amgen
Pfizer
Enbrel
Epogen
anemia
Biogen Idec
MS
Avonex
multiple sclerosis
arthritis
Biogen expects MS sales hit from Gilenya
Fierce Pharma
Wed, 01/12/11 - 07:17 pm
Biogen Idec
Gilenya
MS
multiple sclerosis
Sanofi Is Discussing Lemtrada Payments With Genzyme
Bloomberg
Mon, 01/10/11 - 12:38 pm
Sanofi
Lemtrada
Genzyme
MS
multiple sclerosis
Opexa soars on talks with FDA over MS drug
Marketwatch
Wed, 01/5/11 - 11:10 am
FDA
MS
Opexa
multiple sclerosis
Tovaxin
Biogen Idec begins selling Tysabri in India
Bizjournals.com
Tue, 12/28/10 - 01:11 pm
Indian
Tysabri
Biogen Idec
MS
multiple sclerosis
Teva Pharma Rises on Optimism of Reduced Competition for Copaxone MS Drug
Bloomberg
Mon, 12/27/10 - 08:24 am
Teva Pharmaceuticals
Copaxone
multiple sclerosis
MS
FDA
Teva May Face Copaxone Copy From Novartis, Momenta as Soon as Next Month
Bloomberg
Thu, 12/23/10 - 08:38 am
Teva Pharmaceuticals
Novartis
Copaxone
Momenta
generics
MS
multiple sclerosis
Biogen Idec, Elan seek to update Tysabri labeling
Marketwatch
Wed, 12/22/10 - 09:00 am
Elan
Biogen Idec
Tysabri
MS
multiple sclerosis

Pages